Inventor · disambiguated record
Mitchell Shirvan
Also filed as: SHIRVAN MITCHELL
13 granted patents·11 pending applications·209 citations·filing 1993–2020
91Inventor score
Top patents by PatentIndex Score
24 records- 0195US6528685B2Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Mar 4, 2003·47 cites·25 claims
- 0295US5914349ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Jun 22, 1999·50 cites·18 claims
- 0393US10398641B2Compositions and methods for treating rosacea and acneFOAMIX PHARMACEUTICALS LTD·Filed 2017·Granted Sep 3, 2019·15 cites·4 claims
- 0484US11324691B2Compositions and methods for treating rosacea and acneVYNE THERAPEUTICS INC·Filed 2020·Granted May 10, 2022·1 cites·26 claims
- 0584US6555585B2Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorderTEVA PHARMA·Filed 2001·Granted Apr 29, 2003·20 cites·16 claims
- 0684US5585358ADerivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agentsYISSUM RESEARCH DEV CORP OF TH·Filed 1993·Granted Dec 17, 1996·71 cites·19 claims
- 0781US10849847B2Compositions and methods for treating rosacea and acneFOAMIX PHARMACEUTICALS LTD·Filed 2019·Granted Dec 1, 2020·2 cites·10 claims
- 0873US8288442B2Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disordersSHIRVAN MITCHELL·Filed 2009·Granted Oct 16, 2012·1 cites·12 claims
- 0967US10940241B2Formation of stable cartilageUS HEALTH·Filed 2018·Granted Mar 9, 2021·1 cites·27 claims
- 1065US8574902B2Activated leukocyte composition and uses for wound healingSHIRVAN MITCHELL·Filed 2011·Granted Nov 5, 2013·1 cites·12 claims
- 1162US2021000842A1Tetracycline management of egfr inhibitor associated dermatosesFOAMIX PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1258US2019307778A1Tetracycline management of egfr inhibitor associated dermatosesFOAMIX PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1355US2004204495A1Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment of prevention of pain and/or headache disordersTEVA PHARMA·Filed 2004·Application pending·0 cites
- 1453US9132154B2Activated leukocyte composition and uses for wound healingSHIRVAN MITCHELL·Filed 2013·Granted Sep 15, 2015·0 cites·9 claims
- 1549US2003212142A1Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorderYISSUM RES DEV CO·Filed 2003·Application pending·0 cites
- 1649US2013071465A1Activated leukocyte composition and uses for wound healingSHIRVAN MITCHELL·Filed 2012·Application pending·0 cites
- 1748US2002052418A1Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disordersFiled 2001·Application pending·0 cites
- 1846US9168287B2Activated leukocyte conditioned supernatant and uses for wound healingSHIRVAN MITCHELL·Filed 2011·Granted Oct 27, 2015·0 cites·12 claims
- 1946US2008152630A1Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissueGINIS IRENE·Filed 2007·Application pending·0 cites
- 2045US2018235984A1Tetracycline management of egfr inhibitor associated dermatosesFOAMIX PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2139US2015352151A1Activated leukocyte composition and uses for wound healingMACROCURE LTD·Filed 2015·Application pending·0 cites
- 2238US9439950B2Activated leukocyte conditioned supernatant and uses for wound healingMACROCURE LTD·Filed 2015·Granted Sep 13, 2016·0 cites·16 claims
- 2334US2015071892A1Activated Immunostimulatory Cell Composition for Therapy of InfectionMACROCURE LTD·Filed 2013·Application pending·0 cites
- 2432US2015030635A1Activated Immunostimulatory Cell Composition and Uses ThereofMACROCURE LTD·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →